Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(20):1581-1582; doi:10.1093/jnci/94.20.1581
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chan, K. Y. K.
Right arrow Articles by Khoo, U.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, K. Y. K.
Right arrow Articles by Khoo, U.-S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 20, 1581-1582, October 16, 2002
© 2002 Oxford University Press

CORRESPONDENCE

Re: Population-Based Case–Control Study of HER2 Genetic Polymorphism and Breast Cancer Risk

Kelvin Y. K. Chan, Annie N. Y. Cheung, Shea-Ping Yip, Hin-Hin Ko, Tsz-Wan Lai, Ui-Soon Khoo

Affiliations of authors: K. Y. K. Chan, A. N. Y. Cheung, T. W. Lai, U.-S. Khoo Department of Pathology, The University of Hong Kong, Hong Kong; H. H. Ko, Department of Pathology, The University of Hong Kong, and Pacific Bridge Project, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; S. P. Yip, Biomedical Science Section, School of Nursing, The Hong Kong Polytechnic University, Hong Kong.

Correspondence to: Ui-Soon Khoo, F.R.C.Path. (U.K.), Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Pokfulam Rd., Hong Kong (e-mail: uskhoo@pathology.hku.hk).

The first 10% of the full text of this article appears below.

Human epidermal growth factor receptor 2 (HER2) is a proto-oncogene encoding a transmembrane glycoprotein with tyrosine kinase activity. The amplification and overexpression of this gene have been observed in breast and ovarian cancers and are associated with the response of breast cancers to chemotherapy. A single nucleotide polymorphism (SNP) at codon 655 resulting in a valine to isoleucine change (Val655Ile) was reported in the Journal . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?